Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints - PubMed (original) (raw)
. 2008 Nov;116(5):507-15.
doi: 10.1007/s00401-008-0431-x. Epub 2008 Sep 23.
Affiliations
- PMID: 18810470
- DOI: 10.1007/s00401-008-0431-x
Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints
José Luna-Muñoz et al. Acta Neuropathol. 2008 Nov.
Abstract
In recent years, we have used a variety of tau immunological markers combined with the dye thiazin red (TR), an accurate marker to differentiate the fibrillar from the nonfibrillar state of both amyloid-beta and tau in Alzheimer's disease (AD). In this study, we used TR as a potential diagnostic marker of AD in frozen-thawed (F-T) brain tissue and imprint cytology. Control experiments included the use of Thioflavin-S staining, fixed tissue, and some double-labeled material with TR and selected tau markers, including AT100, MC1, Alz-50, TG-3, Tau-C3, and S396. Our results indicate that TR retains its strong affinity for both tangles and plaques in unfixed F-T tissue and imprint cytology. This information provides a potential use of TR as an accurate diagnostic tool for the rapid postmortem diagnosis of AD neuropathology. This study shows the advantages of TR on cytology mainly because tools for the fast postmortem diagnosis of AD are practically nonexistent. In addition, we observed Tau-C3 immunoreactivity in extracellular tangles, suggesting that the Tau-C3 epitope is characteristically stable. Moreover, this study demonstrates that chemical fixation is not necessarily required for tau immunoreactivity on histological sections.
Similar articles
- Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
Uchihara T, Shibuya K, Nakamura A, Yagishita S. Uchihara T, et al. Acta Neuropathol. 2005 Mar;109(3):299-305. doi: 10.1007/s00401-004-0947-7. Epub 2004 Dec 24. Acta Neuropathol. 2005. PMID: 15619127 - Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA, Nafe R, Schlote W. van de Nes JA, et al. Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1. Brain Res. 2008. PMID: 18455153 - The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J, Selkoe DJ. Hardy J, et al. Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994. Science. 2002. PMID: 12130773 Review. - Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH. Swerdlow RH. Neurobiol Aging. 2007 Oct;28(10):1465-80. doi: 10.1016/j.neurobiolaging.2006.06.021. Epub 2006 Jul 31. Neurobiol Aging. 2007. PMID: 16876913 Review.
Cited by
- High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease.
Bouvier DS, Jones EV, Quesseveur G, Davoli MA, A Ferreira T, Quirion R, Mechawar N, Murai KK. Bouvier DS, et al. Sci Rep. 2016 Apr 19;6:24544. doi: 10.1038/srep24544. Sci Rep. 2016. PMID: 27090093 Free PMC article. - Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A, Ontiveros-Torres MÁ, Harrington CR, Montiel-Sosa JF, Prandiz RG, Bocanegra-López P, Sorsby-Vargas AM, Bravo-Muñoz M, Florán-Garduño B, Villanueva-Fierro I, Perry G, Garcés-Ramírez L, de la Cruz F, Martínez-Robles S, Pacheco-Herrero M, Luna-Muñoz J. Martínez-Maldonado A, et al. J Alzheimers Dis. 2021;79(4):1517-1531. doi: 10.3233/JAD-201139. J Alzheimers Dis. 2021. PMID: 33459640 Free PMC article. - Amyloid beta inhibits olfactory bulb activity and the ability to smell.
Alvarado-Martínez R, Salgado-Puga K, Peña-Ortega F. Alvarado-Martínez R, et al. PLoS One. 2013 Sep 26;8(9):e75745. doi: 10.1371/journal.pone.0075745. eCollection 2013. PLoS One. 2013. PMID: 24086624 Free PMC article. - PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease.
Luna-Viramontes NI, Campa-Córdoba BB, Ontiveros-Torres MÁ, Harrington CR, Villanueva-Fierro I, Guadarrama-Ortíz P, Garcés-Ramírez L, de la Cruz F, Hernandes-Alejandro M, Martínez-Robles S, González-Ballesteros E, Pacheco-Herrero M, Luna-Muñoz J. Luna-Viramontes NI, et al. Front Cell Neurosci. 2020 Sep 10;14:247. doi: 10.3389/fncel.2020.00247. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33132840 Free PMC article. - Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions.
Croft CL, Goodwin MS, Ryu DH, Lessard CB, Tejeda G, Marrero M, Vause AR, Paterno G, Cruz PE, Lewis J, Giasson BI, Golde TE. Croft CL, et al. Acta Neuropathol. 2021 Mar;141(3):359-381. doi: 10.1007/s00401-021-02264-9. Epub 2021 Jan 26. Acta Neuropathol. 2021. PMID: 33496840 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous